AVEO Oncology
AVEO
#7099
Rank
C$0.72 B
Marketcap
C$20.72
Share price
0.00%
Change (1 day)
166.77%
Change (1 year)

AVEO Oncology (AVEO) - Total debt

Total debt on the balance sheet as of September 2022 : C$53.43 Million

According to AVEO Oncology 's latest financial reports the company's total debt is C$53.43 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

AVEO Oncology - Total debt on balance sheet (from 2008 to 2022)

Total debt by year

Year Total debt Change
2021-12-31C$48.39 M162.16%
2020-12-31C$18.45 M-10.35%
2019-12-31C$20.59 M-20.58%
2018-12-31C$25.92 M11.61%
2017-12-31C$23.23 M23.45%
2016-12-31C$18.81 M43.23%
2015-12-31C$13.13 M-45.18%
2014-12-31C$23.96 M17.23%
2013-12-31C$20.44 M-21.04%
2012-12-31C$25.89 M5.31%
2011-12-31C$24.58 M5.1%
2010-12-31C$23.39 M12.6%
2009-12-31C$20.77 M-18.85%
2008-12-31C$25.6 M70.2%
2007-12-31C$15.04 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Biogen
BIIB
C$9.10 B 16,937.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$3.73 B 6,894.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
C$22.93 M-57.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$70.51 B 131,857.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$58.72 B 109,792.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$75.41 B 141,024.61%๐Ÿ‡บ๐Ÿ‡ธ USA